Astex Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Astex Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Astex Pharmaceuticals Inc Strategy Report
- Understand Astex Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Astex Pharmaceuticals Clinical Trials
Determine Astex Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Astex Pharmaceuticals Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Study of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants with Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL) | GDCT0457475 | ASTX-6660 | Oncology | Anaplastic Large Cell Lymphoma (ALCL); Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy; Follicular Lymphoma; Natural Killer Cell Lymphomas; Peripheral T-Cell Lymphomas (PTCL); T-Cell Lymphomas | Phase I/II | Ongoing, recruiting | Astex Pharmaceuticals Inc |
| A Phase I-II Study Investigating the All Oral Combination of the Menin Inhibitor SNDX-5613 with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE) | GDCT0454713 | (cedazuridine + decitabine); revumenib | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia | Phase I/II | Ongoing, recruiting | University of Texas MD Anderson Cancer Center |
| Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer | GDCT0448259 | ASTX-6660 | Oncology | Head And Neck Cancer; Head And Neck Cancer Squamous Cell Carcinoma; Head And Neck Carcinoma; Hypopharyngeal Cancer; Laryngeal Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer | Phase 0 | Ongoing, recruiting | Emory University |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer